Highlights and Quick Summary
- Shareholders Equity (Total) for the quarter ending September 30, 2022 was $4.4 Million (a -21.24% decrease compared to previous quarter)
- Year-over-year quarterly Shareholders Equity (Total) decreased by -33.06%
- Annual Shareholders Equity (Total) for 2021 was $6.58 Million (a -148.02% decrease from previous year)
- Annual Shareholders Equity (Total) for 2020 was $-13.7 Million (a 15.38% increase from previous year)
- Annual Shareholders Equity (Total) for 2019 was $-11.9 Million (a 38.02% increase from previous year)
Visit stockrow.com/BBLG
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Shareholders Equity (Total) of Bone Biologics Corp.
Most recent Shareholders Equity (Total)of BBLG including historical data for past 10 years.Interactive Chart of Shareholders Equity (Total) of Bone Biologics Corp.
Bone Biologics Corp. Shareholders Equity (Total) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $4.4 | $5.59 | $6.04 | – |
| 2021 | $6.58 | $-15.13 | $0.0 | $0.0 | $6.58 |
| 2020 | – | $-13.69 | $-13.24 | $-12.84 | $-13.69 |
| 2019 | – | – | – | $-11.87 | $-11.87 |
| 2018 | – | – | – | – | $-8.6 |
| 2017 | – | – | – | – | $-8.4 |
| 2016 | – | – | – | – | $-8.36 |
Business Profile of Bone Biologics Corp.
Sector: Healthcare
Industry: Medical Devices